Changes in quality of life and disease‐related symptoms in patients with polycythemia vera receiving ruxolitinib or standard therapy
暂无分享,去创建一个
M. Griesshammer | S. Verstovsek | R. Mesa | A. Vannucchi | F. Passamonti | C. Harrison | F. Pane | T. Masszi | S. Durrant | I. Côté | Mark M. Jones | S. Parasuraman | P. Zachée | J. Kiladjian | D. Habr | H. Zhen | Jingjin Li